Vericel Investor Relations Material
Latest events
Q4 2023
Vericel
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Vericel Corporation
Access all reports
Vericel Corporation is a commercial-stage biopharmaceutical company that engages in the research, development, manufacture and distribution of cellular therapies for sports medicine and severe burn care markets. The company has two product candidates: Carticel, its autologous cultured chondrocytes product for the treatment of articular cartilage defects due to degenerative joint diseases; and AlloCello, its ex vivo expanded allogeneic progenitor cells product for the treatment of critical limb ischemia. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.
Key slides for Vericel Corporation
Q3 2023
Vericel Corporation
J.P. Morgan 42nd Annual Healthcare Conference 2024
Vericel Corporation
Latest articles
Daniel Ek: Co-founder and CEO of Spotify
Explore Daniel Ek's journey from a tech-savvy teenager to the co-founder and CEO of Spotify and the most influential person in the music industry.
28 Mar 2024
Companies That Had Their IPO in 1992: A Cautiously Optimistic Market
1992 marked a relatively cool IPO landscape and stock market sentiment, in the wake of the early 90s recession.
28 Mar 2024
Remembering Daniel Kahneman: Transforming Psychology and Economics
Explore Daniel Kahneman's legacy in psychology and economics, highlighting his impact on decision-making and behavioral economics.
28 Mar 2024
Ticker symbol
Country
🇺🇸 United States